TCL Archive Drug Approvals: FDA Approves Vectibix in mCRC With KRAS Companion Diagnostic May 30, 2014
TCL Archive Phase II Study Meets Primary Endpoint, Demonstrating Overall Survival of 5.2 Months September 27, 2013